Stephanie M. Bonventre

Stephanie Bonventre practices at Moffitt Cancer Hospital in Tampa, Florida, part of Moffitt Cancer Center.

Stephanie Bonventre's NPI, 1427440544, was assigned on February 26, 2015. Stephanie Bonventre holds Florida license PA9108453.

Stephanie Bonventre's primary practice is Moffitt Cancer Hospital, at 12902 Magnolia Dr, Tampa, FL 33612. Stephanie Bonventre also practices at H. Lee Moffitt Cancer Center and Research Institute Hospital, Inc., 10920 McKinley Dr, Tampa, FL 33612.

Stephanie Bonventre's primary practice is Moffitt Cancer Hospital in Tampa, Florida, part of Moffitt Cancer Center. The medical group on file is Moffitt Cancer Center. Dmand AI also links Stephanie Bonventre to 3 more group practices and clinics, 2 medical groups, 1 breast imaging center and 1 hospital outpatient department, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Stephanie Bonventre practices, 6 sites in all. Vendor and product names are available with a free account.

Physician assistant is Stephanie Bonventre's primary specialty in the NPI Registry, under taxonomy code 363A00000X. Stephanie Bonventre is licensed in Florida.

CMS data shows 387 Medicare services from Stephanie Bonventre across 3 procedure codes in 2024, for 168 Medicare patients. Medicare paid $19,576 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 168 Medicare patients who saw Stephanie Bonventre in 2024. The largest group is 65 to 74, with 121 patients. 75% of them have cancer, and 71% have high cholesterol. 13% are also on Medicaid. Their average risk score is 2.20, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Stephanie Bonventre's median patient age at 61, with 99% women.

In 2024, Stephanie Bonventre wrote 541 Medicare Part D claims for 166 patients. 84% of them were for generic drugs. CMS names the drug for 431 of them, across 11 drugs with 11 or more claims each, at $665,888 in total drug cost.

Stephanie Bonventre accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Stephanie Bonventre as offering telehealth.

CMS Open Payments shows 1 general payment to Stephanie Bonventre from 1 drug or device company in 2025. Food and beverage make up the largest share, 100% of the total. Eli Lilly and Company paid the most, $122.